HRP20192109T1 - Novi spoj i proces - Google Patents

Novi spoj i proces Download PDF

Info

Publication number
HRP20192109T1
HRP20192109T1 HRP20192109TT HRP20192109T HRP20192109T1 HR P20192109 T1 HRP20192109 T1 HR P20192109T1 HR P20192109T T HRP20192109T T HR P20192109TT HR P20192109 T HRP20192109 T HR P20192109T HR P20192109 T1 HRP20192109 T1 HR P20192109T1
Authority
HR
Croatia
Prior art keywords
compound
formula
reaction
process according
hydrogen
Prior art date
Application number
HRP20192109TT
Other languages
English (en)
Croatian (hr)
Inventor
Peter Lionel Spargo
Original Assignee
Verona Pharma Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verona Pharma Plc filed Critical Verona Pharma Plc
Publication of HRP20192109T1 publication Critical patent/HRP20192109T1/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HRP20192109TT 2016-07-28 2017-07-27 Novi spoj i proces HRP20192109T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1613054.4A GB201613054D0 (en) 2016-07-28 2016-07-28 New compound and process
EP17748880.6A EP3490988B1 (en) 2016-07-28 2017-07-27 New compound and process
PCT/GB2017/052190 WO2018020249A1 (en) 2016-07-28 2017-07-27 New compound and process

Publications (1)

Publication Number Publication Date
HRP20192109T1 true HRP20192109T1 (hr) 2020-02-21

Family

ID=56936838

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20192109TT HRP20192109T1 (hr) 2016-07-28 2017-07-27 Novi spoj i proces

Country Status (19)

Country Link
US (1) US10710998B2 (enExample)
EP (1) EP3490988B1 (enExample)
JP (1) JP6985367B2 (enExample)
KR (1) KR102396059B1 (enExample)
CN (1) CN109641891B (enExample)
CY (1) CY1122138T1 (enExample)
DK (1) DK3490988T3 (enExample)
ES (1) ES2751948T3 (enExample)
GB (1) GB201613054D0 (enExample)
HR (1) HRP20192109T1 (enExample)
HU (1) HUE046509T2 (enExample)
LT (1) LT3490988T (enExample)
PL (1) PL3490988T3 (enExample)
PT (1) PT3490988T (enExample)
RS (1) RS59566B1 (enExample)
SI (1) SI3490988T1 (enExample)
SM (1) SMT201900582T1 (enExample)
TW (1) TWI739871B (enExample)
WO (1) WO2018020249A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2773142T3 (es) 2014-05-12 2020-07-09 Verona Pharma Plc Nuevo tratamiento
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound
SI4090654T1 (sl) * 2020-01-17 2025-11-28 Lupin Ltd. Metode, postopki in intermediati za pripravo kromanskih spojin
JP2024517583A (ja) 2021-04-29 2024-04-23 ▲蘇▼州盛迪▲亞▼生物医▲薬▼有限公司 イソキノリノン系化合物及びその用途
JP2024545189A (ja) 2021-12-14 2024-12-05 シーツァン ハイスコ ファーマスーティカル カンパニー リミテッド 三環式縮合複素環系pde3/4二重阻害剤及びその用途
GB202202297D0 (en) 2022-02-21 2022-04-06 Verona Pharma Plc Formulation production process
EP4378942A1 (en) 2022-12-02 2024-06-05 Sandoz AG Crystal form of a pde3/4 inhibitor
CN121620356A (zh) * 2023-06-26 2026-03-06 维罗纳制药公司 包含恩塞芬汀的颗粒组合物
WO2025003643A1 (en) 2023-06-26 2025-01-02 Verona Pharma Plc Particulate composition comprising ensifetrine
CN122121878A (zh) 2023-09-06 2026-05-29 维罗纳制药有限公司 用于治疗慢性阻塞性肺病(copd)的恩塞芬汀
WO2025168706A1 (en) 2024-02-07 2025-08-14 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
US20250249008A1 (en) 2024-02-07 2025-08-07 Verona Pharma Plc Pharmaceutical compositions of ensifentrine for chronic obstructive pulmonary disease
WO2025176871A1 (en) 2024-02-23 2025-08-28 Inke, S.A. Process for preparing pyrimido[6,1-a]isoquinoline-4-ones

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ185900A (en) 1976-12-10 1981-04-24 Hoechst Ag Pyrimido (6,1-a) isoquinolin-4-ones medicaments intermediate isoquinolines
FI64370C (fi) 1977-05-05 1983-11-10 Hoechst Ag Foerfarande foer framstaellning av terapeutiskt anvaendbara pyimido-(6,1-a)isokinolin-2-imino-4-onderivat
DE2847693A1 (de) 1978-11-03 1980-05-22 Hoechst Ag Verfahren zur herstellung von pyrimido-(6,1-a)-isochinolin-2-onen
DE3135831A1 (de) 1981-09-10 1983-04-28 Hoechst Ag, 6230 Frankfurt 9,10-substituierte 2-mesitylimino-3-alkyl-3,4,6,7-tetrahydro-2h-pyrimido(6,1-a)isochinolin-4-one, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ZW6284A1 (en) 1983-05-05 1985-10-30 Hoffmann La Roche Novel pyrimidone derivatives
DK1165558T3 (da) 1999-03-31 2004-02-09 Vernalis Ltd Pyrimido[6,1-a]isoquinolin-4-on-derivater
SI2603509T1 (sl) 2010-08-09 2014-10-30 Verona Pharma Plc Kristalinična oblika spojine PIRIMIDIO(6,1-A) IZOKINOLIN-4-ENA
JP6560986B2 (ja) 2013-03-15 2019-08-14 ヴェローナ ファーマ ピーエルシー 複合製剤
ES2773142T3 (es) 2014-05-12 2020-07-09 Verona Pharma Plc Nuevo tratamiento
LT3193835T (lt) 2014-09-15 2018-06-11 Verona Pharma Plc Skysta inhaliuojama vaisto forma, apimanti rpl554
GB201502260D0 (en) 2015-02-11 2015-04-01 Verona Pharma Plc Salt of Pyrimido[6,1-A]Isoquinolin-4-one compound

Also Published As

Publication number Publication date
CN109641891B (zh) 2021-05-04
JP6985367B2 (ja) 2021-12-22
EP3490988B1 (en) 2019-08-28
SI3490988T1 (sl) 2019-11-29
LT3490988T (lt) 2019-10-10
TWI739871B (zh) 2021-09-21
GB201613054D0 (en) 2016-09-14
TW201806951A (zh) 2018-03-01
DK3490988T3 (da) 2019-10-28
KR102396059B1 (ko) 2022-05-10
HUE046509T2 (hu) 2020-03-30
WO2018020249A1 (en) 2018-02-01
PT3490988T (pt) 2019-10-28
EP3490988A1 (en) 2019-06-05
CN109641891A (zh) 2019-04-16
ES2751948T3 (es) 2020-04-02
PL3490988T3 (pl) 2020-02-28
SMT201900582T1 (it) 2019-11-13
JP2019527228A (ja) 2019-09-26
KR20190034231A (ko) 2019-04-01
US20190330206A1 (en) 2019-10-31
RS59566B1 (sr) 2019-12-31
US10710998B2 (en) 2020-07-14
CY1122138T1 (el) 2020-11-25

Similar Documents

Publication Publication Date Title
HRP20220750T1 (hr) Postupak za proizvodnju spoja diariltiohidantoina
JP2019527228A5 (enExample)
HRP20211922T1 (hr) Postupci i intermedijeri za pripravu jak inhibitora
TR201902080T4 (tr) N-asil-(3-sübstitüe)-(8-sübstitüe)-5,6-dihidro-[1,2,4]triazolo[4,3-a]pirazinlerinin yeni kiral sentezleri.
RU2015143637A (ru) Способы получения апоптоз агента
HRP20191932T1 (hr) Sinteza boronatnih soli i njihove uporabe
CA2902624C (en) Method for producing sulfonyl chloride compound
HRP20201582T1 (hr) Polimorf sik inhibitora
JP2018522012A5 (enExample)
PH12016502334A1 (en) Method for producing fused heterocyclic compound
RU2014137470A (ru) Способы и соединения, которые можно использовать для синтеза антагонистов рецепторов орексина-2
PE20080109A1 (es) N-sulfonilacion selectiva de alcoholes sustituidos con 2-aminotrifluoralquilo
HRP20220129T1 (hr) Postupak za pripremu uglavnom dijastereomerno čistog fosforodiamidatnog oligomera, fosforodiamidatni oligomer dobiven takvim postupkom i farmaceutski pripravak koji sadrži takav fosforodiamidatni oligomer
HRP20211072T1 (hr) Sinteza indazola
PH12018500582A1 (en) Crosslinked nucleic acid guna, method for producing same, and intermediate compound
ES2702193T3 (es) Proceso para la preparación de compuestos de isoxazolina ópticamente activos
CN103772278A (zh) 一种重要四氢异喹啉衍生物中间体及其合成方法
HRP20171167T1 (hr) Priprava intermedijera pirimidina koji služe za proizvodnju macitentana
HRP20170711T1 (hr) Kontinuirani postupak za alkilaciju cikličnih tercijarnih amina
NZ730843A (en) Synthesis of copanlisib and its dihydrochloride salt
CA3205634A1 (en) Method for preparing an enantiomerically enriched form of 2-[2-(2-chlorothiazol-5-yl)-2-hydroxy-ethyl]sulfanyl-6-hydroxy-3-methyl-5-phenyl-pyrimidin-4-one
CN104448898A (zh) 一种派洛宁衍生物染料的合成方法
RU2015129994A (ru) Способ получения 1-(4-(4-(3, 4-дихлор-2-фторфениламино)-7-метоксихиназолин-6-илокси)пиперидин-1-ил)проп-2-ен-1-она
HRP20080510T3 (hr) Postupak za priređivanje optički aktivnih derivata 2-(2-piridilmetilsulfinil)-benzimidazola putem inkluzijskog kompleksa s 1,1'-binaftalen-2,2' diolom
Parakhin et al. 4-Hydroxy-3-(polynitromethyl-ONN-azoxy) furazans and some of their derivatives